Brieflands

History

The company was first founded by Seyyed M. Miri and Seyed-M Alavian as an editorial group in a Medical Institute in 2007 to publish its medical journal. After three years of experience, the number of journals increased to 5 journals, and the company launched its first form of business as a VOF (collaboration) professional STM company in Heerlen, the Netherlands, which was called "Kowsarmedical Publishing." Respecting the publishing services (from submission to publishing), especially an in-house "Journal Management System," our journals increased to more than 60 STM journals between 2010 and 2019. Since 2022, "Brieflands" is the new brand name that acts as a "Science, Technical, Medical Publisher" that publishes more than 50 journals with the services provided by 97 expert employees in three different branches.


Business Profile

  • Brieflands is a Registered Trademark with record number 1454012.
  • Brieflands has been registered as a General partnership (Vennootschap onder firma) company in the Chamber of Commerce (Kamer van Koophandel) of the Netherlands since 2010.
  • Nedmedica is our related company which is specialized in Author Services. 
  • Our former branding name was Kowsarmedical Publishing (2010-2021).
 

Recent Submissions

Item
Enhancing Human Error Assessment in Hospitals by Systematic Human Error Reduction and Prediction Approach
(Brieflands, 2025-07-31) Mobin Ebrahimian; Zeinab Abbasi Senjedary; Mahdieh Motie; Mobin Ebrahimian [0000-0001-5366-4116]; Zeinab Abbasi Senjedary [0000-0003-0139-7575]; Mahdieh Motie [0000-0001-8132-7416]
This article does not have an abstract.
Item
Comparison of the Effects of Isoflurane and Propofol as Anesthesia Maintenance on Plasma Mitochondrial DNA Levels in Posterior Spinal Fusion Surgeries
(Brieflands, 2025-06-30) Faranak Behnaz; Mehrak Erfanian; Azita Chegini; Faranak Behnaz [0000-0003-2856-3975]; Azita Chegini [0000-0002-7715-5591]
Background: Tissue injury resulting from surgical procedures leads to the release of various inflammatory agents, such as mitochondrial DNA (mt-DNA). This can trigger inflammatory mechanisms that may harm different organs. Objectives: In this study, we investigated the effects of isoflurane and propofol on mt-DNA levels during posterior spinal fusion (PSF) surgery. Methods: After meeting the inclusion criteria, 40 patients scheduled for PSF surgery were enrolled in a prospective randomized controlled clinical trial and randomly divided into groups receiving propofol or isoflurane for maintenance of anesthesia. Mitochondrial DNA levels were measured before surgery, one hour after induction of anesthesia, in the recovery unit, and 24 hours post-surgery. Results: There was no statistically significant difference between groups regarding age, gender, and mt-DNA levels prior to surgery (P-value > 0.05). However, mt-DNA levels were significantly higher in the isoflurane group one hour after induction of anesthesia (P-value = 0.001), in the recovery unit (P-value = 0.042), and 24 hours after surgery (P-value = 0.018). Conclusions: Propofol was superior to isoflurane, as demonstrated by a lesser elevation in plasma levels of mt-DNA in PSF patients.
Item
Low-Frequency Stimulation as an Effective Therapeutic Approach for Seizure Control in Epilepsy
(Brieflands, 2025-05-31) Nooshin Ahmadirad; Fereshteh Golab; Bita Kouhnavardpour; Mona Bostan Manesh Nikjavan; Fariba Karimzadeh; Fariba Karimzadeh [0000-0002-8805-3486]
Background: Low-frequency stimulation (LFS) is an emerging therapeutic strategy for managing epilepsy, particularly in patients resistant to conventional treatment methods.
Item
Evaluating the Knowledge Retention After Virtual Training of Patient Blood Management Among Hospital’s Personnel After One Year
(Brieflands, 2025-04-30) Azita Chegini; Maryam Zadsar; Ali Boroujerdi Alavi; Azita Chegini [0000-0002-7715-5591]; Maryam Zadsar [0000-0001-9519-4853]
Background: Enhancing the knowledge of healthcare professionals is crucial for improving patient safety, as their education, retraining, experience, and skill sets are vital for patient health. Objectives: To implement patient blood management (PBM), virtual training programs were conducted to train personnel and investigate the effect of this training on their knowledge and sustained learning. Methods: A cross-sectional study was conducted to train the staff of a 160-bed tertiary referral hospital. A total of 243 staff members were randomly recruited to participate in the study at Shahid Lavasani Hospital, Tehran, Iran, between November 2016 and November 2017. The participants included 12 (4.9%) lab technicians, 229 (94.3%) nurses, and 2 (0.8%) physicians. Before training, a test was conducted to assess their level of knowledge. Subsequently, all enrolled staff attended a virtual educational seminar employing an active learning method. The sustainability of knowledge was assessed using the same exam six months and one year later. For comparison, one-way ANOVA, chi-square, and paired t-test were applied. SPSS software version 23 was used for statistical analysis. Results: The average score of the participants was 91.15 ± 10.60, with no correlation between the years of university education and the final score. Six months later, participants were invited to retake the same test in a virtual environment, but only 35 agreed to participate. Their average score was 81.09 ± 10.31 (minimum 52 and maximum 100), showing no significant differences between groups. One year after the initial training, 116 individuals participated in the test, and their average score was 75.60 ± 10.28. After one year, clinical experience and ward-specific challenges significantly influenced their exam performance. Conclusions: Active learning methods and practical applications may enhance long-term knowledge retention following virtual training.
Item
Detection of Carbapenemase Genes in Acinetobacter baumannii Isolates from Al-Azizya Hospital, Wasit, Iraq
(Brieflands, 2025-06-30) Asmaa Jalil Alawi; Fazel Pourahmad; Khadijeh Fattahi; Fazel Pourahmad [0000-0003-0342-1735]
Background: Acinetobacter baumannii is a critical nosocomial pathogen notorious for its multidrug resistance (MDR) and ability to cause severe infections, particularly in intensive care units (ICUs). Carbapenem-resistant A. baumannii (CRAB) poses a significant public health threat due to limited treatment options and high mortality rates. Objectives: This study aimed to detect carbapenemase genes (blaOXA-23, blaOXA-48, blaNDM, and blaVIM) and evaluate antibiotic resistance patterns in A. baumannii isolates from Al-Azizya Hospital, Wasit, Iraq. Methods: Fifty-eight A. baumannii isolates were collected from clinical samples and identified using phenotypic and biochemical tests. Antibiotic susceptibility was assessed via the disk diffusion method, and carbapenemase genes were detected using PCR. Results: All isolates harbored the intrinsic blaOXA-51 gene, confirming their identity as A. baumannii. The prevalence of carbapenemase genes was as follows: blaOXA-23 (26%), blaVIM (24%), blaOXA-48 (22%), and blaNDM (21%). High resistance rates were observed against ceftazidime (100%), meropenem (96%), and imipenem (95%), with aztreonam showing the lowest resistance (59%). Conclusions: These findings highlight the genetic diversity of carbapenem resistance mechanisms in this region and underscore the urgent need for stringent infection control measures, including enhanced surveillance, strict antibiotic stewardship, and the development of novel therapeutic strategies to combat CRAB infections. This study contributes to a better understanding of CRAB’s molecular epidemiology in Iraq and informs strategies to mitigate the spread of MDR A. baumannii in healthcare settings.